Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Perez

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancerRoman Perez-Soler
Clinical Lung Cancer|January 11, 2005
Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancerRoman Perez-Soler
Clinical Lung Cancer|January 24, 2007
Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancerRoman Perez-Soler
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Erlotinib: recent clinical results and ongoing studies in non small cell lung cancerRoman Perez-Soler
Oncology (Williston Park, N.Y.)|May 20, 2010
EGFR TKIs for advanced NSCLC: practical questionsRoman Perez-Soler
Targeted Oncology|May 20, 2009
Skin toxicities associated with epidermal growth factor receptor inhibitorsTianhong Li, Roman Perez-Soler
Drugs|June 21, 2012
Role of erlotinib in the treatment of non-small cell lung cancer: clinical outcomes in wild-type epidermal growth factor receptor patientsBilal Piperdi, Roman Perez-Soler
Molecular Endocrinology (Baltimore, Md.)|December 3, 2005
The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptorSamuel Seoane, Roman Perez-Fernandez
Methods in Molecular Medicine|November 1, 2002
Chemopreventive therapeutics. Inhalation therapies for lung cancer and bronchial premalignancyMissak Haigentz, Roman Perez-Soler
The Lancet. Oncology|January 6, 2018
Leptomeningeal metastases in non-small-cell lung cancerHaiying Cheng, Roman Perez-Soler
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancerRoman Perez-Soler
Clinical Lung Cancer|January 11, 2005
Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancerRoman Perez-Soler
Clinical Lung Cancer|January 24, 2007
Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancerRoman Perez-Soler
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Erlotinib: recent clinical results and ongoing studies in non small cell lung cancerRoman Perez-Soler
Oncology (Williston Park, N.Y.)|May 20, 2010
EGFR TKIs for advanced NSCLC: practical questionsRoman Perez-Soler
Targeted Oncology|May 20, 2009
Skin toxicities associated with epidermal growth factor receptor inhibitorsTianhong Li, Roman Perez-Soler
Drugs|June 21, 2012
Role of erlotinib in the treatment of non-small cell lung cancer: clinical outcomes in wild-type epidermal growth factor receptor patientsBilal Piperdi, Roman Perez-Soler
Molecular Endocrinology (Baltimore, Md.)|December 3, 2005
The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptorSamuel Seoane, Roman Perez-Fernandez
Methods in Molecular Medicine|November 1, 2002
Chemopreventive therapeutics. Inhalation therapies for lung cancer and bronchial premalignancyMissak Haigentz, Roman Perez-Soler
The Lancet. Oncology|January 6, 2018
Leptomeningeal metastases in non-small-cell lung cancerHaiying Cheng, Roman Perez-Soler
Pageof 14